唯科科技(301196.SZ):併購產業重點側重於具備一定產業協同效應的下遊總成類標的,如汽車零部件總成一級供應商、微特電機等機器人零部件相關領域
格隆匯5月20日丨唯科科技(301196.SZ)在投資者互動平臺表示,(1)公司一直在積極尋求合適且有較高性價比的併購標的,公司併購產業重點側重於具備一定產業協同效應的下遊總成類標的,如汽車零部件總成一級供應商、微特電機等機器人零部件相關領域。(2)未來,公司將會根據實際經營情況,本着回報股東、與股東共享經營成果的原則,綜合考慮投資者的合理回報和公司的長遠發展,制定合理的利潤分配方案,具體情況請關注公司後續公告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.